logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Jeremy S. Abramson

massachusetts general hospital cancer center
H指数:69
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Patient-Reported Outcomes in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated with Glofitamab plus Gemcitabine and Oxaliplatin in STARGLO

在STARGLO研究中，接受Glofitamab联合吉西他滨和奥沙利铂治疗复发或难治性弥漫性大B细胞淋巴瘤患者的患者报告结局

Clinical Lymphoma Myeloma and Leukemia
IF2.7
2026-10-110
OAAI
Gareth P. Gregory; Jeremy S. Abramson; Huiqiang Huang; Qingyuan Zhang; Matthew Ku; Dok Hyun Yoon; Christopher P. Fox; Haifaa Abdulhaq; William Townsend; Joan Ashby; Alana Harris; Estefania Mulvihill; Martine Kallemeijn; Murali Kesavan; Richard Ta; Voleak Choeurng; Linda Lundberg; Huilai Zhang
Summary of Research: Brentuximab Vedotin and Nivolumab in Combination with Chemotherapy for Nonbulky, Early-Stage Classical Hodgkin Lymphoma

研究概述： Brentuximab Vedotin和Nivolumab与化疗联合治疗非巨大肿块、早期经典型霍奇金淋巴瘤

Advances in Therapy
IF4
2026-08-290
OAAI
Jeremy S. Abramson; David J. Straus; Nancy L. Bartlett; John M. Burke; Ryan C. Lynch; Eva Domingo Domenech; Brian Hess; Steven R. Schuster; Yuliya Linhares; Mitul Gandhi; Harsh R. Shah; Wojciech Jurczak; Alessandro Re; Uwe Hahn; H. Miles Prince; Wenchuan Guo; Griffith Davis; Linda Ho; Michelle Fanale; Christopher A. Yasenchak; Hun Ju Lee
Venetoclax added to dose-adjusted EPOCH-R for newly diagnosed double-hit lymphomas: phase 2 results from ALLIANCE A051701, an open-label, randomised, controlled, phase 2-3 trial

维奈克拉联合剂量调整的EPOCH-R方案治疗新诊断的双打击淋巴瘤：来自ALLIANCE A051701开放标签、随机对照、II-III期试验的II期结果

Lancet Haematology
IF17.7
2026-08-010
PRE
Abramson, Jeremy S.; Geyer, Susan; Giri, Sharmila; Pederson, Levi; Hudson, Ann; D Hsi, Eric; Mehta-Shah, Neha; Reagan, Patrick M.; Deming, Richard L.; Little, Richard F.; Gore, Steven; Dinner, Shira N.; Vallurupalli, Anusha; Landsburg, Daniel J.; Kahl, Brad; Friedberg, Jonathan W.; Bartlett, Nancy L.; Leonard, John P.
Durable efficacy and manageable long-term safety of lisocabtagene maraleucel in 3L+ FL: 3-year update from TRANSCEND FL

利萨库特根马拉鲁赛尔在3L+ FL中的持久疗效和可管理的长期安全性：TRANSCEND FL研究3年更新

Blood
IF23.1
2026-07-030
OA
Sairah Ahmed; Alejandro Martín García-Sancho; Juan Luis Reguera Ortega; Guillaume Cartron; Aaron P. Rapoport; Koji Izutsu; Hervé Ghesquieres; Hideki Goto; M. Lia Palomba; Jeremy S. Abramson; Peter Borchmann; Ulrich Jäger; Manali Kamdar; Martin Dreyling; Marion Subklewe; Saurabh Dahiya; Loretta J. Nastoupil; Merav Bar; Maria Strocchia; Martina Raggi
Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKs

奥布替尼、奥滨尤妥珠单抗和维奈克拉在慢性淋巴细胞白血病中的长期随访、微小残留病动力学、再治疗、T细胞谱分析和药代动力学

Blood Advances
IF7.1
2026-07-020
OA
Jacob D. Soumerai; Meghan C. Thompson; Ahmet Dogan; Venkatraman Seshan; Kelsey L. Flaherty; Natalie Slupe; Jason Carter; Ephraim Hochberg; Jeffrey A. Barnes; Jeremy S. Abramson; Ariela Noy; Colette Owens; Maria Lia Palomba; Anita Kumar; Lindsey Roeker; Ronald W. Takvorian; Zachary D. Epstein-Peterson; Mark B. Geyer; Gilles Salles; Robert Stuver
Glofitamab plus gemcitabine and oxaliplatin for relapsed/refractory DLBCL: 3-year follow-up of STARGLO

戈利妥昔单抗联合吉西他滨和奥沙利铂治疗复发/难治性弥漫大B细胞淋巴瘤：STARGLO研究的3年随访

Blood Advances
IF7.1
2026-06-130
OAAI
Jeremy S. Abramson; William Townsend; Christopher P. Fox; Matthew Ku; Mark Hertzberg; Hui-Qiang Huang; Huilai Zhang; Dok Hyun Yoon; Won-Seog Kim; Haifaa Abdulhaq; Charles Herbaux; Jan M. Zaucha; Qing-Yuan Zhang; Hung Chang; Yanyan Liu; Chan Yoon Cheah; Herve Ghesquieres; Estefania Mulvihill; Murali Kesavan; Martine Kallemeijn
Five-year survival outcomes of lisocabtagene maraleucel in R/R LBCL from the TRANSCEND NHL 001 study

lisocabtagene maraleucel在TRANSCEND NHL 001研究中复发/难治性LBCL的五年生存结局

Blood
IF23.1
2026-06-050
OAAI
Jeremy S. Abramson; Tanya Siddiqi; Leo I. Gordon; Matthew Lunning; Michael Wang; Jon Arnason; Manali Kamdar; David G. Maloney; Mazyar Shadman; Charalambos Andreadis; Alison Sehgal; Scott R. Solomon; Nilanjan Ghosh; Juliana E. Hidalgo-López; Jing Wang; Xue Ding; Ken Ogasawara; Ashvin Singh; M. Lia Palomba
Outcomes of tafasitamab and lenalidomide in large B-cell lymphoma based on prior CD19-directed CAR T exposure

基于先前CD19定向CAR T暴露的大B细胞淋巴瘤中Tafasitamab和Lenalidomide的治疗效果

HEMASPHERE
IF14.6
2025-11-180
OAAI
Merrill, Mwanasha H.; Redd, Robert A.; Lambert, Nicholas; Caimi, Paolo F.; Pullarkat, Priyanka; Godby, Richard C.; Bond, David A.; Wehmeyer, Graham T.; Romancik, Jason; Amoozgar, Behzad; Leslie, Lori; Nastoupil, Loretta J.; Crombie, Jennifer L.; Abramson, Jeremy S.; Khurana, Arushi; Nowakowski, Grzegorz S.; Maddocks, Kami; Rutherford, Sarah C.; Kahl, Brad; Okwali, Michelle; Buege, Michael J.; Batlevi, Connie L.; Armand, Philippe; Salles, Gilles; Qualls, David A.
Clinical Presentation, Management and Outcome of Tumor inflammation-associated neurotoxicity (TIAN) in CNS lymphoma treated with CD19-CAR T-cell therapy

肿瘤炎症相关神经毒性（TIAN）在经CD19-CAR T细胞疗法治疗的CNS淋巴瘤中的临床表现、管理与转归

NEURO-ONCOLOGY
IF13.4
2025-11-010
OAAI
Kaulen, Leon D.; Martinez-Lage, Maria; Abramson, Jeremy S.; Karschnia, Philipp; Doubrovinskaia, Sofia; Shankar, Ganesh; Choi, Bryan; Ramundo, Christopher M.; Ehret, Felix; Barnes, Jeffrey A.; El-Jawahri, Areej; Hochberg, Ephraim P.; Johnson, P. Connor; Soumerai, Jacob D.; Plotkin, Scott; Batchelor, Tracy; Wick, Wolfgang; Maus, Marcela, V; Chen, Yi-Bin; Frigault, Matthew J.; Dietrich, Jorg
Prognostic effects and immune biomarkers associated with gasdermin protein expression in diffuse large B-cell lymphoma
JOURNAL OF IMMUNOLOGY
IF3.4
2025-11-010
PRE
Monette, Zijun Yidan Xu; Kong, Xue; Xu, Zhenming; Yan, Hui; Au, Qingyan; Nunns, Harry; Tzankov, Alexandar; Visco, Carlo; Dybkaer, Karen; Hsi, Eric; Zhao, Xiaoxian; Chiu, April; Bhagat, Govind; Zu, Youli; Go, Heounjeon; Moller, Michael; Parsons, Benjamin M.; Montes-Moreno, Santiago; Maurilio, Ponzoni; Ferreri, Andres J. M.; Sohani, Aliyah R.; Abramson, Jeremy S.; Xu, Bing; Li, Yong; Young, Ken
A Retrospective Study of Treatment and Outcomes in Synchronous Systemic and Central Nervous System Large B-cell Lymphoma

同步系统性及中枢神经系统弥漫大B细胞淋巴瘤的治疗与预后回顾性研究

Blood Advances
IF7.1
2025-11-010
OAAI
J. Erika Haydu; Robert A. Redd; Matthew M. Lei; Ephraim P. Hochberg; Jeffrey A. Barnes; Philippe Armand; Jacob D. Soumerai; April F. Eichler; Eric D. Jacobsen; Justin T. Jordan; Caron A. Jacobson; Ann S. LaCasce; Isabel Arrillaga-Romany; J.R. McFaline-Figueroa; Scott R. Plotkin; Ronald W. Takvorian; Ugonma N. Chukwueke; Jennifer L. Crombie; P. Connor Johnson; Philipp Karschnia; Jorg M. Dietrich; Lakshmi Nayak; Jeremy S. Abramson
CRS or ICANS Are Rare Beyond 2 Weeks After Lisocabtagene Maraleucel Infusion: Data From Clinical Trials and the Real-World Setting

CRS或ICANS在lisocabtagene maraleucel输注2周后较为罕见：来自临床试验和真实世界的数据

Transplantation and Cellular Therapy
IF4.4
2025-10-240
PRE
Bradley D. Hunter; Matthew Lunning; Mazyar Shadman; Sairah Ahmed; Jeremy S. Abramson; Miguel-Angel Perales; Nausheen Ahmed; Abu-Sayeef Mirza; Iris Isufi; Matthew J. Frigault; Jennifer L. Crombie; David B. Miklos; Alberto Vasconcelos; Alessandro Crotta; David Bernasconi; Debasmita Roy; Eric Bleickardt; Marcelo C. Pasquini; Manali Kamdar
B-Cell Lymphomas 3.2025 Featured Updates to the NCCN Guidelines

B细胞淋巴瘤 3.2025 NCCN指南特色更新

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK
IF16.4
2025-10-010
PRE
Zelenetz, Andrew D.; Gordon, Leo I.; Abramson, Jeremy S.; Advani, Ranjana H.; Andreadis, Babis; Bartlett, Nancy L.; Budde, L. Elizabeth; Caimi, Paolo F.; Chang, Julie E.; Christian, Beth; DeVos, Sven; Dholaria, Bhagirathbhai; Fayad, Luis E.; Habermann, Thomas M.; Hamid, Muhammad Saad; Hernandez-Ilizaliturri, Francisco; Hu, Boyu; Karimi, Yasmin; Kelsey, Christopher R.; King, Rebecca; Kline, Justin; Krivacic, Susan; Lacasce, Ann S.; Landsburg, Daniel; Lim, Megan; Messmer, Marcus; Rabinovitch, Rachel; Ramakrishnan, Praveen; Reid, Erin; Roberts, Kenneth B.; Saeed, Hayder; Saito, Naoyuki G.; Smith, Stephen D.; Swinnen, Lode J.; Tuscano, Joseph; Vose, Julie M.; Dwyer, Mary; Sundar, Hema
Novel Devimistat Results in Complete Remissions in Heavily Pre-Treated Burkitt Lymphoma in a phase II trial

新型Devimistat结果在II期试验中导致重度预治疗Burkitt淋巴瘤完全缓解

Blood Advances
IF7.1
2025-07-210
OAAI
Raphael Steiner; Liana Nikolaenko; Ranjit Nair; Venkatraman Seshan; Swetha Kambhampati Thiruvengadam; Niloufer Khan; Jeremy S. Abramson; Steven Horwitz; Matthew Matasar; Colette Owens; Ildefonso Ismael Rodriguez Rivera; David J. Straus; Timothy S. Pardee; Sanjeev Luther; Sabrina Saboukoulou; Win Su Thet; Shreya Vemuri; Ariela Noy
Prognostic gene expression and microRNA profiling signatures and genetic alterations in primary testicular diffuse large B-cell lymphoma

预后基因表达和微RNA表达谱特征以及原发性睾丸弥漫性大B细胞淋巴瘤的遗传改变

Blood Cancer Journal
IF11.6
2025-07-170
PREAI
Wenyu Shi; Zijun Y. Xu-Monette; Youchao Jia; Alexandar Tzankov; Heounjeong Go; Ling Li; Maurilio Ponzoni; Yafei Wang; Qiongli Zhai; Anamarija M. Perry; Shi Wang; Xiaoxiao Wang; April Chiu; Mina L. Xu; Carlo Visco; Karen Dybkaer; Henry Withers; Mark Long; Alyssa F. Yuan; Yi Miao; Everardo Macias; Dehong Wu; Wen Shuai; Bangchen Wang; Jianyong Li; Govind Bhagat; Youli Zu; Zenggang Pan; William Choi; Santiago Montes-Moreno; Weina Chen; J. Han van Krieken; Michael B. Møller; Xinfang Yu; Benjamin M. Parsons; Shanxiang Zhang; Eric D. Hsi; Aliyah R. Sohani; Jeremy S. Abramson; Andrés J. M. Ferreri; Bing Xu; Yong Li; Ken H. Young
Clinical presentation, management and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell Therapy

TIAN的临床表现、管理及CD19-CAR T细胞治疗下在中枢神经系统淋巴瘤中的结局

Blood
IF23.1
2025-07-170
PRE
Leon D. Kaulen; Maria Martinez-Lage; Jeremy S. Abramson; Philipp Karschnia; Sofia Doubrovinskaia; Ganesh M. Shankar; Bryan D. Choi; Christopher M. Ramundo; Felix Ehret; Jeffrey A. Barnes; Areej El-Jawahri; Ephraim P. Hochberg; P. Connor Johnson; Jacob D. Soumerai; Scott R. Plotkin; Tracy T. Batchelor; Wolfgang Wick; Marcela V. Maus; Yi-Bin Chen; Matthew J. Frigault; Jorg Dietrich

研究方向

暂未获取到该数据
A
Ann S. LaCasce
H 指数:66论文数:388被引数:1.8万
N
Nancy L. Bartlett
H 指数:96论文数:937被引数:4.7万
J
Jeffrey A. Barnes
H 指数:23论文数:135被引数:2,557
E
Ephraim P. Hochberg
H 指数:54论文数:249被引数:9,091
R
Ranjana H. Advani
H 指数:100论文数:840被引数:4.7万
A
Andrew D. Zelenetz
H 指数:96论文数:761被引数:4.2万
J
Julie M. Vose
H 指数:110论文数:910被引数:5.8万
L
Leo I. Gordon
H 指数:91论文数:826被引数:4.2万
H
Hema Sundar
H 指数:47论文数:109被引数:9,719
M
Manali Kamdar
H 指数:35论文数:256被引数:6,699